Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Mapstone

Showing results (121-130 of 147) with videos related to

Pageof 15
Sort By:
Ebiomedicine|November 5, 2024
The effects of mosaicism on biological and clinical markers of Alzheimer's disease in adults with Down syndromeLaura Xicota, Lam-Ha T Dang, Alice Lee, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 21, 2026
The impact of congenital heart disease on the timing of Alzheimer's disease in Down syndromeJulianne G Clina, Brian C Helsel, Sigan L Hartley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 19, 2023
Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndromePriyanka Gorijala, M Muaaz Aslam, Lam-Ha T Dang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 20, 2024
The Abca7<sup>V1613M</sup> variant reduces Aβ generation, plaque load, and neuronal damageClaire A Butler, Adrian Mendoza Arvilla, Giedre Milinkeviciute, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2025
The Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS): A 10-year reportBenjamin L Handen, Mark Mapstone, Sigan Hartley, et al.
Journal of Alzheimer'S Disease : JAD|December 18, 2020
Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down SyndromeMelissa E Petersen, Michael S Rafii, Fan Zhang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 7, 2025
The striatum is an early, accurate indicator of amyloid burden using [<sup>11</sup>C]PiB in Down syndrome: Comparison of two radiotracersMax McLachlan, Brecca Bettcher, Andrew McVea, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 16, 2024
Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndromeEmily K Schworer, Benjamin L Handen, Melissa Petersen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 27, 2025
A neuropathology case report of a woman with Down syndrome who remained cognitively stable: Implications for resilience to neuropathologyJr-Jiun Liou, Jerry Lou, Lisi Flores-Aguilar, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersJr-Jiun Liou, Tales Santini, Milos D Ikonomovic, et al.
Pageof 15

Showing results (121-130 of 147) with videos related to

Sort By:
Pageof 15
Ebiomedicine|November 5, 2024
The effects of mosaicism on biological and clinical markers of Alzheimer's disease in adults with Down syndromeLaura Xicota, Lam-Ha T Dang, Alice Lee, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 21, 2026
The impact of congenital heart disease on the timing of Alzheimer's disease in Down syndromeJulianne G Clina, Brian C Helsel, Sigan L Hartley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 19, 2023
Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndromePriyanka Gorijala, M Muaaz Aslam, Lam-Ha T Dang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 20, 2024
The Abca7<sup>V1613M</sup> variant reduces Aβ generation, plaque load, and neuronal damageClaire A Butler, Adrian Mendoza Arvilla, Giedre Milinkeviciute, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2025
The Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS): A 10-year reportBenjamin L Handen, Mark Mapstone, Sigan Hartley, et al.
Journal of Alzheimer'S Disease : JAD|December 18, 2020
Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down SyndromeMelissa E Petersen, Michael S Rafii, Fan Zhang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 7, 2025
The striatum is an early, accurate indicator of amyloid burden using [<sup>11</sup>C]PiB in Down syndrome: Comparison of two radiotracersMax McLachlan, Brecca Bettcher, Andrew McVea, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 16, 2024
Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndromeEmily K Schworer, Benjamin L Handen, Melissa Petersen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 27, 2025
A neuropathology case report of a woman with Down syndrome who remained cognitively stable: Implications for resilience to neuropathologyJr-Jiun Liou, Jerry Lou, Lisi Flores-Aguilar, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersJr-Jiun Liou, Tales Santini, Milos D Ikonomovic, et al.
Pageof 15